Curacle Co., Ltd. (365270) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Curacle Co., Ltd. (365270:KRX), powered by AI.

Current Price
₩14,760
P/E Ratio
-18.0
Market Cap
325.8B
Sector
Healthcare
What is the Curacle Co., Ltd. stock price forecast?

Curacle Co., Ltd. is currently trading at ₩14,760. View real-time AI analysis on Alpha Lenz.

What is Curacle Co., Ltd. insider trading activity?

View the latest insider trading data for Curacle Co., Ltd. on Alpha Lenz.

What is Curacle Co., Ltd.'s P/E ratio?

Curacle Co., Ltd.'s P/E ratio is -18.0.

Curacle Co., Ltd.

KRX · 365270
₩14,760+1,220(+9.01%)Market closedKRX regular session 09:00–15:30 KST
Ask about Curacle Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Curacle Co., Ltd. trades at a P/E of -18.0 (undervalued) with modest ROE of -54.0%.

Ask for details

Company Overview

Curacle Co., Ltd. is a biopharmaceutical company dedicated to the research and development of therapeutic solutions focused primarily on innovative treatments for vascular and metabolic diseases. The company's primary function is to develop clinical-stage biopharmaceutical therapies that address significant unmet medical needs. Curacle operates predominantly within the healthcare and life sciences sector, where its products aim to impact medical technology and treatment options. By leveraging advanced scientific research and clinical trials, Curacle seeks to offer novel solutions for complex health conditions. Within the financial market, Curacle represents a part of the innovative biotech segment, highlighting its role as a player in advancing pharmaceutical development. Curacle's progress and breakthroughs hold implications for healthcare advancements, offering potential improvements in quality of life for patients worldwide.

CEO유재현
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩325,782,601,920Market Cap
₩7,101,460Revenue
22.07MShares Out
0Employees

Margins

100.00%Gross
-215382.17%EBITDA
-232394.04%Operating
-255057.91%Pre-Tax
-255057.91%Net

Valuation

-17.99P/E
8.78P/B
45875.44EV/Sales
-21.91EV/EBITDA
-24.18P/FCF

Growth (CAGR)

-87.44%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-32.20%ROA
-54.03%ROE
-29.36%ROIC

Financial Health

₩4,040,028,080Cash & Cash Equivalents
₩12,081,343,510Net Debt
43.47%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Curacle Co., Ltd. (ticker: 365270) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $325.8B.

The current price is ₩14,760 with a P/E ratio of -17.99x and P/B of 8.78x.

ROE is -54.03% and operating margin is -232394.04%. Annual revenue is $7M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Curacle Co., Ltd. (365270) Stock Forecast 2026 ₩14,760 — Price, Financials & Analyst Targets | Alpha Lenz